Metformin Heumann

Metformin Hydrochloride, the active ingredient in Metformin Heumann, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults. GNH USA supplies Metformin Heumann as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Heumann is a biguanide oral antidiabetic used to improve glycaemic control in several glucose‑related conditions.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose by improving insulin sensitivity. Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes through hepatic glucose reduction. Polycystic ovary syndrome (PCOS): reduces insulin resistance and may improve menstrual regularity.

Metformin Hydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste in the mouth. - Mild headache. - Decreased appetite. - Weight loss. - Vitamin B12 deficiency with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe hypoglycaemia when combined with insulin or secretagogues. - Hepatotoxicity: elevated liver enzymes. - Skin reactions: rash or urticaria. - Hemolytic anaemia in patients with G6PD deficiency. - Pancreatitis (very rare).

Metformin should be used with caution and under medical supervision. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic impairment: evaluate liver function as reduced clearance may increase risk of lactic acidosis. - Cardiovascular disease: monitor for signs of heart failure. - Alcohol consumption: advise limiting intake to reduce lactic acidosis risk. - Pregnancy and lactation: discuss potential risks with a healthcare professional. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations. - Certain antivirals (e.g., dolutegravir): can increase metformin exposure.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function when combined. - Oral corticosteroids: may raise blood glucose, requiring dose adjustment.